Novo Nordisk (China) Pharmaceuticals Co., Ltd.

xinhua ⋅ 2024-02-07 ⋅ views ⋅ Business

Novo Nordisk A/S is a biopharmaceutical company founded in 1923. Having always been committed to innovation, it is a leader in the field of diabetes. The Company is headquartered in Copenhagen, Denmark, and its products are sold in more than 170 countries and regions. The Tianjin plant of Novo Nordisk (China) Pharmaceutical Co., Ltd. was established in 1995 and settled in TEDA in 2002. It successively completed large-scale expansions in 2004 and 2008. At present, the Company has two production divisions in TEDA, with a total coverage of nearly 130,000 square meters. It has become Novo Nordisk’s only supplier of durable insulin injection device in the world, and an important insulin preparation and filling production base, taking an important strategic position in the Company’s business in the Asia Pacific region.

- THE END -

Reward

This article is written by @xinhua Revised and published on 2024-02-07

This article is submitted by a member and does not represent the position of our website. We do not guarantee the accuracy, validity, timeliness, and completeness of the information. If there is any infringement or illegal information, please contact QQ customer service at 3372575805 for handling. If reproduced, please indicate the source: https://wap.zhll.com/Business/828.html

Tianjin Futaba-Sc Mechanical C

Novozymes (China) Biotechnolog